TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness.
Du R, Shen W, Liu Y, Gao W, Zhou W, Li J, Zhao S, Chen C, Chen Y, Liu Y, Sun P, Xiang R, Shi Y, Luo Y.
Du R, et al. Among authors: gao w.
Signal Transduct Target Ther. 2019 Dec 13;4:60. doi: 10.1038/s41392-019-0098-x. eCollection 2019.
Signal Transduct Target Ther. 2019.
PMID: 31871777
Free PMC article.